Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Micrografts improve hair density and thickness without side effects.

Men with Kennedy disease have less chance of hair loss.

Use minoxidil for hair loss treatment, and finasteride for men.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Minoxidil effectively treats female pattern hair loss.

No true link between AGA and insulin resistance, but coexistence may worsen AGA.

PRP treatment improves hair density and thickness for alopecia, but needs more research.

Minoxidil effectively treats hair loss, with better results in women.

Hormone therapy affects hair growth in transgender individuals, with testosterone potentially causing hair loss in trans men and estrogen reducing facial/body hair in trans women; treatment options vary.

Platelet-Rich Plasma (PRP) therapy can promote hair growth and improve facial aesthetics, including reducing acne scars and facial burns, and it works best with three initial monthly injections.

The article concludes that developing in vitro models for human hair structures is important for research and reducing animal testing, but there are challenges like obtaining suitable samples and the models' limitations.

New method measures female hair loss: Female Pattern Hair Loss Severity Index (FPHL-SI).

Hair loss risk is influenced by multiple genes.

Platelet-rich plasma (PRP) is a safe and potentially effective way to treat hair loss, especially when combined with minoxidil.

Some treatments like methotrexate with prednisone might help juvenile morphea, but more research is needed to confirm.

Minoxidil promotes hair regrowth, but more research needed for effectiveness and response factors.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

DSC cell injections significantly improved hair density and diameter, showing potential as a hair loss treatment.

DHEA may help with sexual function when used intravaginally by menopausal women but is similar to hormone therapy in other aspects and might cause more side effects like acne and hair loss.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Topical minoxidil helps treat female pattern hair loss, but more research needed for other treatments.

TrichoScan often makes mistakes and needs improvement for correct hair growth analysis.

The first in-prison dermatology clinic in the U.S. faced challenges and found certain skin conditions common among inmates, with rare cases of serious skin cancer.

SVF-PRP therapy effectively reverses hair loss effects.

Minoxidil foam effectively promotes hair growth and reduces hair loss in men.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

Platelet-Rich Plasma (PRP) treatment can potentially increase hair density and quality in people with hair loss, but more research is needed to confirm its effectiveness.

AGA increased yearly, type I most common, and family history and seborrheic dermatitis often linked.